Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Furlan

Showing results (181-190 of 225) with videos related to

Pageof 23
Sort By:
European Journal of Neurology|March 9, 2022
Integrated evaluation of a panel of neurochemical biomarkers to optimize diagnosis and prognosis in amyotrophic lateral sclerosisYuri Matteo Falzone, Teuta Domi, Alessandra Mandelli, et al.
Journal of Neurology|April 4, 2025
Recall vaccination increases detectable B-cell reactivity in persons with multiple sclerosis treated with ocrelizumabLucia Moiola, Alessandra Mandelli, Maciej Tarkowski, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|October 7, 2025
IL-1β contributes to neurological disability in NMOSD AQP4 + PatientsAntonio Bruno, Angela Borrelli, Gianluca Lauritano, et al.
Neurorehabilitation and Neural Repair|August 22, 2019
Interleukin-6 Disrupts Synaptic Plasticity and Impairs Tissue Damage Compensation in Multiple SclerosisMario Stampanoni Bassi, Ennio Iezzi, Francesco Mori, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 19, 2023
Granulocyte activation markers in cerebrospinal fluid differentiate acute neuromyelitis spectrum disorder from multiple sclerosisDavid Leppert, Mitsuru Watanabe, Sabine Schaedelin, et al.
Annals of Neurology|October 31, 2012
Myeloid microvesicles are a marker and therapeutic target for neuroinflammationClaudia Verderio, Luca Muzio, Elena Turola, et al.
Neurology|July 18, 2020
Serum neurofilament light as a biomarker in progressive multiple sclerosisRaju Kapoor, Kathryn E Smith, Mark Allegretta, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 20, 2009
Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitisDiego Centonze, Luca Muzio, Silvia Rossi, et al.
Genes|May 28, 2022
Interleukin 6 SNP <i>rs1818879</i> Regulates Radiological and Inflammatory Activity in Multiple SclerosisAntonio Bruno, Ettore Dolcetti, Federica Azzolini, et al.
International Journal of Molecular Sciences|August 29, 2024
An IL-5 Single-Nucleotide Polymorphism Influences Neuroinflammation and Prospective Disease Activity in Multiple SclerosisEttore Dolcetti, Fabio Buttari, Antonio Bruno, et al.
Pageof 23

Showing results (181-190 of 225) with videos related to

Sort By:
Pageof 23
European Journal of Neurology|March 9, 2022
Integrated evaluation of a panel of neurochemical biomarkers to optimize diagnosis and prognosis in amyotrophic lateral sclerosisYuri Matteo Falzone, Teuta Domi, Alessandra Mandelli, et al.
Journal of Neurology|April 4, 2025
Recall vaccination increases detectable B-cell reactivity in persons with multiple sclerosis treated with ocrelizumabLucia Moiola, Alessandra Mandelli, Maciej Tarkowski, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|October 7, 2025
IL-1β contributes to neurological disability in NMOSD AQP4 + PatientsAntonio Bruno, Angela Borrelli, Gianluca Lauritano, et al.
Neurorehabilitation and Neural Repair|August 22, 2019
Interleukin-6 Disrupts Synaptic Plasticity and Impairs Tissue Damage Compensation in Multiple SclerosisMario Stampanoni Bassi, Ennio Iezzi, Francesco Mori, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 19, 2023
Granulocyte activation markers in cerebrospinal fluid differentiate acute neuromyelitis spectrum disorder from multiple sclerosisDavid Leppert, Mitsuru Watanabe, Sabine Schaedelin, et al.
Annals of Neurology|October 31, 2012
Myeloid microvesicles are a marker and therapeutic target for neuroinflammationClaudia Verderio, Luca Muzio, Elena Turola, et al.
Neurology|July 18, 2020
Serum neurofilament light as a biomarker in progressive multiple sclerosisRaju Kapoor, Kathryn E Smith, Mark Allegretta, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 20, 2009
Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitisDiego Centonze, Luca Muzio, Silvia Rossi, et al.
Genes|May 28, 2022
Interleukin 6 SNP <i>rs1818879</i> Regulates Radiological and Inflammatory Activity in Multiple SclerosisAntonio Bruno, Ettore Dolcetti, Federica Azzolini, et al.
International Journal of Molecular Sciences|August 29, 2024
An IL-5 Single-Nucleotide Polymorphism Influences Neuroinflammation and Prospective Disease Activity in Multiple SclerosisEttore Dolcetti, Fabio Buttari, Antonio Bruno, et al.
Pageof 23